Nexstim Plc (HEL:NXTMH)
14.50
+0.15 (1.05%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
| Diagnostics Systems | 3.15M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Systems Growth | 1.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Therapy Continuous | 2.55M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Therapy Continuous Growth | 28.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Therapy Systems | 1.64M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Therapy Systems Growth | 68.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Continuous | 1.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Continuous Growth | 18.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Licensing | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
| Other | 71.01K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -72.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America | 3.31M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | 1.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe | 3.03M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Growth | 35.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finland | 2.32M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Finland Growth | 55.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 71.01K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -72.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|